drugset / Trial / NCT07319520
Clinical Trial to Evaluate the Efficacy and Safety of DW4902
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DW4902 in Patients with Uterine Fibroids.
Timeline
- Start
- 2021-10-06
- Primary completion
- 2024-11-11
- Completion
- 2024-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW4902 | Unknown | 160 mg | Oral |
| Subject | DW4902 | Unknown | 240 mg | Oral |
| Subject | DW4902 | Unknown | 320 mg | Oral |